Company Filing History:
Years Active: 2004
Title: Christopher Thomas Privalle: Innovator in Hemoglobin Solutions
Introduction
Christopher Thomas Privalle is an accomplished inventor based in Durham, NC (US). He is known for his significant contributions to the field of biochemistry, particularly in the development of modified hemoglobin solutions. His innovative approach has the potential to enhance the safety and efficacy of hemoglobin-based products.
Latest Patents
Privalle holds a patent for "Methods for the synthesis of a modified hemoglobin solution." This invention employs a filtration step during the hemoglobin purification process that substantially decreases viral contamination of a hemoglobin solution. The filtration means can be used to separate hemoglobin and several endogenous antioxidant enzymes from red blood cell stroma and potential adventitious agents. The purified hemoglobin/antioxidant composition is then subjected to a chemical modification process. The resulting modified hemoglobin/antioxidant composition is then fractionated to remove unmodified hemoglobin species and residual reactants, formulated in electrolytes, and rendered sterile. The resulting modified hemoglobin product is substantially free of viral contamination and contains at least one endogenous antioxidant enzyme that retains antioxidant activity. Privalle's innovative work has led to the creation of a safer and more effective hemoglobin product.
Career Highlights
Throughout his career, Privalle has worked with notable companies such as Apex Biosciences, Inc. and Breonics Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of hemoglobin solutions.
Collaborations
Privalle has collaborated with talented individuals in his field, including Cyrus John Stacey and Todd Talarico. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Christopher Thomas Privalle is a notable inventor whose work in modified hemoglobin solutions has the potential to revolutionize the field of biochemistry. His innovative methods and collaborations highlight his commitment to advancing medical science.